Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapy

International Journal of Cardiology

Volumn 191, Issue , 2015, Pages 286-293

  Kaufmann, Beat A ^a   Goetschalckx, Kaatje ^a,b   Min, Son Y ^a   Maeder, Micha T ^a,c   Bucher, Urs ^a   Nietlispach, Fabian ^a,d   Bernheim, Alain M ^a,e   Pfisterer, Matthias E ^a   Rocca, Hans Peter Brunner La ^a,f  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Cardiology Division   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e TRIEMLI HOSPITAL   (Switzerland)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biomarkers; Heart failure; Left ventricular ejection fraction; Outcome

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; LEFT VENTRICULAR END DIASTOLIC VOLUME INDEX; LEFT VENTRICULAR END SYSTOLIC VOLUME INDEX; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; CLINICAL TRIAL; ECHOGRAPHY; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 84951267380     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.04.282     Document Type: Article

References (27)

1. S.D. Solomon, N. Anavekar, H. Skali, and et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients Circulation 112 2005 3738 3744
2. H.D. White, R.M. Norris, M.A. Brown, P.W. Brandt, R.M. Whitlock, and C.J. Wild Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction Circulation 76 1987 44 51
3. B. Greenberg, M.A. Quinones, C. Koilpillai, and et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy Circulation 91 1995 2573 2581
4. R.N. Doughty, G.A. Whalley, G. Gamble, S. MacMahon, and N. Sharpe Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand heart failure research collaborative group J. Am. Coll. Cardiol. 29 1997 1060 1066
5. M. St John Sutton, S. Ghio, T. Plappert, and et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure Circulation 120 2009 1858 1865
6. J.C. Tardif, E. O'Meara, M. Komajda, and et al. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the shift echocardiography substudy Eur. Heart J. 32 2011 2507 2515
7. J.A. Ezekowitz, and F.A. McAlister Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials Eur. Heart J. 30 2009 469 477
8. R.A. Weir, P.B. Mark, C.J. Petrie, and et al. Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect? Am. Heart J. 157 2009 1088 1096
9. J.G. Cleland, K. Swedberg, F. Follath, and et al. The Euroheart failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis Eur. Heart J. 24 2003 442 463
10. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, and et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
11. J.L. Januzzi Jr., S.U. Rehman, A.A. Mohammed, and et al. Use of amino-terminal pro-b-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J. Am. Coll. Cardiol. 58 2011 1881 1889
12. R.B. Weiner, A.L. Baggish, A. Chen-Tournoux, and et al. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the proBNP outpatient tailored chronic heart failure (protect) study Eur. J. Heart Fail. 15 2013 342 351
13. M. Pfisterer, P. Buser, H. Rickli, and et al. BNP-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial JAMA 301 2009 383 392
14. H.P. Brunner-La Rocca, P.T. Buser, R. Schindler, and et al. Management of elderly patients with congestive heart failure - design of the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) Am. Heart J. 151 2006 949 955
15. R.M. Lang, M. Bierig, R.B. Devereux, and et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J. Am. Soc. Echocardiogr. 18 2005 1440 1463
16. L.G. Rudski, W.W. Lai, J. Afilalo, and et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography J. Am. Soc. Echocardiogr. 23 2010 685 713 (quiz 786-688)
17. P. Thavendiranathan, A.D. Grant, T. Negishi, J.C. Plana, Z.B. Popovic, and T.H. Marwick Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy J. Am. Coll. Cardiol. 61 2013 77 84
18. S. Muzzarelli, M.T. Maeder, S. Toggweiler, and et al. Frequency and predictors of hyperkalemia in patients ≥ 60 years of age with heart failure undergoing intense medical therapy Am. J. Cardiol. 109 2012 693 698
19. D.J. van Veldhuisen, G.C. Linssen, T. Jaarsma, and et al. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J. Am. Coll. Cardiol. 61 2013 1498 1506
20. L. Di Biase, A. Auricchio, A. Sorgente, and et al. The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy Eur. Heart J. 29 2008 2497 2505
21. B. Greenberg, M.A. Quinones, C. Koilpillai, and et al. Effects of long-term enalapril on cardiac structure and function in patients with left ventricular dysfunction Circulation 91 1995 2573 2581
22. C. Linde, W.T. Abraham, M.R. Gold, and et al. Cardiac Resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study J. Am. Coll. Cardiol. 56 2010 1826 1831
23. M. Wong, L. Staszewsky, R. Latini, and et al. Valsartan benefits left ventricular structure and function in heart failure: Val-heft echocardiographic study J. Am. Coll. Cardiol. 40 2002 970 975
24. M.R. Bristow, E.M. Gilbert, W.T. Abraham, and et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Mocha investigators Circulation 94 1996 2807 2816
25. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (n-BNP) concentrations Lancet 355 2000 1126 1130
26. J.G. Lainchbury, R.W. Troughton, K.M. Strangman, and et al. N-terminal pro-b-type natriuretic peptide-guided treatment for chronic heart failure: results from the battlescarred (nt-proBNP-assisted treatment to lessen serial cardiac readmissions and death) trial J. Am. Coll. Cardiol. 55 2009 53 60
27. R.W. Troughton, C.M. Frampton, H.P. Brunner-La Rocca, and et al. Effect of b-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis Eur. Heart J. 35 2014 1559 1567